CytomX Therapeutics, Inc. (NASDAQ:CTMX) headquartered in South San Francisco, will host a conference call for the investment community to discuss the 3Q20 earnings result on 5th November 2020 at 5:00 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.cytomx.com
Earnings Expectation
CytomX Therapeutics, Inc. is expected to report third quarter earnings results, after market close, on Thursday 5th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.48 per share from revenue of $ 16.34 million. Looking ahead, the full year loss are expected at $ 1.05 per share on the revenues of $ 98.93 million.
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops a novel class of investigational antibody therapeutics based on its Probody technology platform for the treatment of cancer.
